A century ago, the French-Canadian microbiologist Félix d’Herelle, recognized an “invisible microbe” that he proposed was a ‘bacteriophage’ virus with bacteria-devouring properties. Read More at William C. Summers, “Bacteriophage Therapy”, (Annu. Rev. Microbiol. 2001. 55:437–51) Eliava Institute The Eliava Institute was founded in 1923 by distinguished Georgian physician, bacteriologist and phage researcher Prof. George…
Patient education: Cystic fibrosis (CF) What is cystic fibrosis? — Cystic fibrosis is a disease of exocrine gland function that involves multiple organ systems. It is an autosomal recessive disorder caused by an abnormal gene called – cystic fibrosis transmembrane conductance regulator gene (CFTR). The symptoms are associated with the production of hyper viscous…
Patient education: Irritable bowel syndrome What is irritable bowel syndrome? – Irritable bowel syndrome, or “IBS,” is a condition that causes belly pain and problems with bowel movements. Some people with the condition have frequent, watery bowel movements (diarrhea). Others do not have enough bowel movements (constipation). Some patients switch back and forth between…
https://www.youtube.com/watch?v=lhPPJJZ6SUg In today’s medical landscape, finding a viable alternative to antibiotics for resistant infections has become a global priority. As traditional treatments fail against superbugs, bacteriophage therapy emerges as a breakthrough solution. This video explores how the Eliava Phage Therapy Center utilizes personalized phages to target specific pathogens without harming beneficial bacteria. By providing a…
http://www.youtube.com/watch?v=YI3tsmFsrOg&feature=youtu.be Did you know that the bacteriophage deadliest being on our planet is actually a virus that saves human lives? While it holds the title of the world’s most efficient killer of bacteria, its precision is what makes it a medical miracle. This video explores the fascinating nature of the bacteriophage deadliest being, showcasing its…
The research could pave the way for bacteriophage treatments for other diseases. We are one step closer to seeing a new kind of treatment to combat inflammatory bowel disease (IBD). On February 15, the U.S. Food and Drug Administration (FDA) gave its seal of approval to a new Phase 1/2 clinical trial in humans…
On the evening of Nov. 7, Steffanie Strathdee sent out a cryptic tweet: “#Phage researchers! I am working with a team to get Burkholderia cepacia phages to treat a 25 y old woman with CF whose infection has failed all #antibiotics. We need lytic non-lysogenic phage URGENTLY to find suitable phage matches. Email if you…
Antibiotic resistance — the phenomenon in which bacteria stop responding to certain antibiotics — is a growing threat around the world. It’s expected to kill 10 million people annually by 2050. And it hasn’t been easy to develop new drugs in order to stay ahead of the problem. Many major pharmaceutical companies have stopped developing new…
As overused antibiotics become less and less effective, a tantalising discovery may revolutionise healthcare Steffanie Strathdee feared the worst when husband Tom Patterson comatosed Husband of 13 years lay in a deep coma, the victim of an aggressive superbug His heart, lungs and major organs were all shutting down with little hope left Apparently miraculous…
International research involving a Monash biologist shows that bacteriophage therapy – a process whereby bacterial viruses attack and destroy specific strains of bacteria – can be used successfully to treat systemic, multidrug resistant bacterial infections. The latest research, published in Antimicrobial Agents & Chemotherapeutics has wide implications for antibiotic resistance, which the World Health Organization…